Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Net Margin (2016 - 2024)

Avanos Medical (AVNS) has disclosed Net Margin for 11 consecutive years, with 0.17% as the latest value for Q4 2024.

  • Quarterly Net Margin rose 12.0% to 0.17% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.04% through Sep 2025, up 84.0% year-over-year, with the annual reading at 0.84% for FY2024, 687.0% up from the prior year.
  • Net Margin hit 0.17% in Q4 2024 for Avanos Medical, up from 0.94% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 20.65% in Q2 2021 to a low of 71.79% in Q4 2021.
  • Historically, Net Margin has averaged 5.53% across 5 years, with a median of 0.23% in 2023.
  • Biggest five-year swings in Net Margin: plummeted -4530bps in 2021 and later skyrocketed 7575bps in 2022.
  • Year by year, Net Margin stood at 26.49% in 2020, then plummeted by -171bps to 71.79% in 2021, then surged by 106bps to 3.96% in 2022, then crashed by -107bps to 0.29% in 2023, then soared by 42bps to 0.17% in 2024.
  • Business Quant data shows Net Margin for AVNS at 0.17% in Q4 2024, 0.94% in Q3 2024, and 1.46% in Q2 2024.